SCHEMBL9693336

SCHEMBL9693336

CN1C(=O)NC(=O)/C1=C\c1cc(N2CCCCC2)ccc1[N+](=O)[O-]

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.52
▸ ALDH1A1 P00352 10/20 0.50
▸ MAPT P10636 15/20 0.49
▸ CYP1A2 P05177 4/20 0.49
▸ CYP2C19 P33261 4/20 0.49
▸ CYP2C9 P11712 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.48
▸ KMT2A Q03164 4/20 0.47
▸ LMNA P02545 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.45
▸ HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9693341 1.00 HPGD (0.52) HPGDALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL10753482 0.80 TSHR (0.44) HPGDALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL10753480 0.80 TSHR (0.44) HPGDALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL9691948 0.80 HPGD (0.51) HPGDALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL9691943 0.80 HPGD (0.51) HPGDALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL9693493 0.78 MAPT (0.51) HPGDALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL9693489 0.78 MAPT (0.51) HPGDALDH1A1MAPTCYP1A2CYP2C19
SCHEMBL10754644 0.77 ALDH1A1 (0.47) HPGDALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL10754642 0.77 ALDH1A1 (0.47) HPGDALDH1A1MAPTL3MBTL1KMT2A
SCHEMBL44794 0.75 HPGD (0.64) HPGDALDH1A1MAPTCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0252503-B1 AMINOIMIDAZOQUINOLINE DERIVATIVES Bristol-Myers Squibb Company (US) 1992-11-19 — — EP disclosed
EP-0252503-A1 Aminoimidazoquinoline derivatives Bristol-Myers Squibb Company (US) 1988-01-13 — — EP disclosed
US-4701459-A 7-amino-1,3-dihydro-2H-imidazo[4,5-b]quinolin 2-ones and method for inhibiting phosphodiesterase and blood platelet aggregation BRISTOL-MYERS COMPANY (US) 1987-10-20 — — US disclosed
Send feedback